About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in Secaucus, United States and employs approximately 46,000 people. With a market capitalization of $22 billion, DGX is a large established company.
Key Statistics
- Current Price
- $199.70
- Market Cap
- $22.22B
- 52-Week High
- $213.50
- 52-Week Low
- $157.20
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +15.61% | $172.74 | $199.70 |
| 2025 | +17.20% | $147.39 | $172.74 |
| 2024 | +11.77% | $131.87 | $147.39 |
| 2023 | -10.05% | $146.60 | $131.87 |
| 2022 | -7.80% | $159.00 | $146.60 |
| 2021 | +47.86% | $107.53 | $159.00 |
| 2020 | +14.11% | $94.24 | $107.53 |
| 2019 | +31.13% | $71.87 | $94.24 |
| 2018 | -13.84% | $83.41 | $71.87 |
| 2017 | +9.16% | $76.42 | $83.41 |
| 2016 | +31.90% | $57.93 | $76.42 |
| 2015 | +8.37% | $53.46 | $57.93 |
| 2014 | +28.05% | $41.75 | $53.46 |
| 2013 | -6.24% | $44.52 | $41.75 |
| 2012 | +1.50% | $43.86 | $44.52 |
| 2011 | +8.37% | $40.47 | $43.86 |
| 2010 | -9.95% | $44.95 | $40.47 |
| 2009 | +17.24% | $38.34 | $44.95 |
| 2008 | -1.08% | $38.76 | $38.34 |
| 2007 | +0.58% | $38.54 | $38.76 |
| 2006 | +3.67% | $37.17 | $38.54 |
| 2005 | +8.49% | $34.26 | $37.17 |
| 2004 | +31.66% | $26.02 | $34.26 |
| 2003 | +28.49% | $20.25 | $26.02 |
| 2002 | -20.65% | $25.52 | $20.25 |
| 2001 | +1.00% | $25.27 | $25.52 |
| 2000 | +364.62% | $5.44 | $25.27 |
| 1999 | +71.58% | $3.17 | $5.44 |
| 1998 | +5.56% | $3.00 | $3.17 |
| 1997 | +11.57% | $2.69 | $3.00 |
Valuation
DGX currently trades at a trailing P/E ratio of 22.8, which is considered moderate relative to the broader market. The forward P/E of 17.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 3.1. The price-to-sales ratio is 2.0.
Dividends
Quest Diagnostics Incorporated pays a dividend to shareholders with a current yield of 1.72%. This translates to $3.44 per share annually. The payout ratio of 36% indicates sustainable dividend coverage.
Risk & Volatility
DGX has a beta of 0.63, indicating it is less volatile than the overall market. The stock's 52-week range is $157.20 to $213.50, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 16 analyst opinions, DGX has a consensus "buy" rating. The average price target of $218.50 suggests 9.4% upside from current levels.
Frequently Asked Questions
What does Quest Diagnostics Incorporated do? ▼
Quest Diagnostics Incorporated is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Secaucus, United States.
What sector is DGX in? ▼
DGX operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
When did DGX go public? ▼
Quest Diagnostics Incorporated went public in 1996, making it a 30-year-old public company as of 2026.
How much would $1,000 invested in DGX 5 years ago be worth today? ▼
A $1,000 investment in DGX five years ago would be worth approximately $1,838 today, representing a 83.8% return.
Does DGX pay dividends? ▼
Yes, Quest Diagnostics Incorporated pays a dividend with a current yield of 1.72%, which is $3.44 per share annually.
What is DGX's market cap? ▼
Quest Diagnostics Incorporated has a market capitalization of $22 billion, classifying it as a large-cap company.
What is DGX's P/E ratio? ▼
DGX has a trailing P/E ratio of 22.8 and a forward P/E of 17.4, which measures how much investors are paying per dollar of earnings.
Is DGX a buy, hold, or sell? ▼
Based on 16 opinions, DGX has a consensus "buy" rating. The average price target is $218.5.
Last updated: 3/14/2026